Clonorchiasis is an infection with the liver fluke Clonorchis sinensis, a trematode that inhabits the bile ducts [2]. The provided sources characterize it as a neglected parasitic zoonosis and place it within a broader group of liver-fluke diseases that includes opisthorchiasis [1][3][4][5]. It is described as having a complex life cycle involving humans, animal reservoirs, and two kinds of intermediate hosts [1].
Disease Profile
ParasiticClonorchiasis
肝吸虫病
Clonorchiasis is a parasitic liver fluke infection caused by Clonorchis sinensis, and it is discussed together with related opisthorchiasis because of shared epidemiologic and control features [1][2]. Available source material describes it as a public-health burden concentrated in eastern Asia, with chronic infection linked to liver and biliary complications, most importantly cholangiocarcinoma [1][2]. The evidence base here supports a conservative surveillance profile focused on zoonotic transmission, chronic hepatobiliary morbidity, and prevention through exposure reduction and control measures [1][2].
The source material indicates that clonorchiasis is primarily associated with liver and biliary disease rather than an acute syndromic description [2]. Chronic infection is linked to hepatobiliary complications, with cholangiocarcinoma identified as the most important complication in the reviewed literature [1][2]. The snippets do not provide source-backed detail on symptom timing, severity staging, or complication frequency beyond this chronic hepatobiliary association [1][2].
Clonorchiasis is described as occurring mainly in East Asia, where it reflects regional social-ecological systems and a long-standing cultural practice of consuming raw freshwater fish [2]. A 2024 review states that clonorchiasis and related liver-fluke infections impose a considerable public-health burden in eastern Asia, southeastern Asia, and eastern Europe, respectively, but the precise distribution and exact number of infected people remain unknown for clonorchiasis itself [1][2]. The literature notes that biological, cultural, ecological, economic, and social factors all contribute to transmission, and that mapping the current distribution remains a pressing research need [1].
Transmission is supported by the life cycle description involving humans, animal reservoirs, and two kinds of intermediate hosts [1]. The available sources specifically link clonorchiasis in East Asia to the cultural habit of consuming raw freshwater fish, indicating an exposure pathway through fish consumption [2]. Further source-backed detail on persistence in the environment or additional exposure mechanisms is not yet available [1][2].
The source material identifies people in endemic East Asian settings, especially those with raw freshwater fish consumption, as a key exposure group [2]. Because the life cycle involves humans and animal reservoirs, populations in close contact with the relevant ecological settings may be at risk, but the snippets do not provide a more detailed source-backed risk stratification [1].
The main control approach described in the sources is preventive chemotherapy with praziquantel, usually combined with behavior change through information, education, and communication, together with environmental control or environmental management [1][2]. The literature also mentions integrated control strategies and novel approaches under development, including fish vaccine and biological control [1]. The sources do not provide a detailed prevention schedule or operational guidance beyond these broad control measures [1][2].
For surveillance purposes, clonorchiasis should be read as a zoonotic hepatobiliary infection whose burden is concentrated in defined endemic regions and whose chronic complications may be substantial even when the exact number of infections is uncertain [1][2]. Stool microscopy is described as widely used in epidemiologic surveys and for individual diagnosis, while immunologic methods are used for screening and molecular methods for species differentiation in reference laboratories [1]. The available sources therefore support surveillance that combines burden mapping, exposure-context interpretation, and attention to chronic biliary outcomes [1][2].
- 1 Qian M-B et al. Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control. Clin Microbiol Rev. 2024 Mar 14. PMID: 38169283. doi: 10.1128/cmr.00009-23. PubMed: https://pubmed.ncbi.nlm.nih.gov/38169283/
- 2 Qian MB et al. Clonorchiasis. Lancet. 2016 Feb 20. PMID: 26299184. doi: 10.1016/S0140-6736(15)60313-0. PubMed: https://pubmed.ncbi.nlm.nih.gov/26299184/
- 3 Clonorchiasis. Neglected Parasitic Zoonoses of Helminth Origin. 2025. doi: 10.1201/9781032697499-11. DOI: https://doi.org/10.1201/9781032697499-11
- 4 Clonorchiasis. The Cambridge World History of Human Disease. 1993. doi: 10.1017/chol9780521332866.091. DOI: https://doi.org/10.1017/chol9780521332866.091
- 5 Clonorchiasis. Encyclopedia of Parasitology. None. doi: 10.1007/978-3-540-48996-2_643. DOI: https://doi.org/10.1007/978-3-540-48996-2_643
- 6 Chai JY et al. Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update. Korean J Parasitol. 2021 Jun. PMID: 34218593. doi: 10.3347/kjp.2021.59.3.189. PubMed: https://pubmed.ncbi.nlm.nih.gov/34218593/
- B66.1
- 1F89.0
Figure 1 | Full historical trajectories across all reporting countries.
Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.
Dataset Archive
Supplementary Data | Multi-country disease dataset
Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.
Source Register
Official sources and update cadences used to construct the downloadable dataset.
China
Monthly notifiable infectious disease reports published by China CDC.
Official sourceChina
Official China public health bulletin and query portal.
Official sourceChina
Biomedical literature discovery feed used as supplementary context.
Official source